Subscribe to our Newsletters !!
Few developments in science and technology have be
In modern pharmaceutical and laboratory settings,
A new COVID-19 variant, BA.3.2, informally called
Alembic Pharmaceuticals Limited (Alembic) today an
2026 marks a new chapter for the pharmaceutical an
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to a fresh and forward-lo
AstraZeneca said on Tuesday it began early stage trials to get an antibody-based treatment for the prevention and treatment of COVID-19, as the British drugmaker also ploughs on with its vaccine candidate.
The trial will assess if AZD7442, a blend of two monoclonal antibodies, is tolerable and safe in up to 48 healthy participants between the ages of 18 and 55 years in the uk together with the backing of the USA.
